Brownlee M - Search Results

1

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Hammes HP, et al. Among authors: brownlee m. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11555-8. doi: 10.1073/pnas.88.24.11555. Proc Natl Acad Sci U S A. 1991. PMID: 1763069 Free PMC article.

2

Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes.

Hammes HP, Federoff HJ, Brownlee M. Hammes HP, et al. Among authors: brownlee m. Mol Med. 1995 Jul;1(5):527-34. Mol Med. 1995. PMID: 8529118 Free PMC article.

3

Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat.

Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G. Hammes HP, et al. Among authors: brownlee m. Diabetes. 1998 Mar;47(3):401-6. doi: 10.2337/diabetes.47.3.401. Diabetes. 1998. PMID: 9519746

4

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.

Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K. Hammes HP, et al. Among authors: brownlee m. Diabetologia. 1994 Jan;37(1):32-5. doi: 10.1007/BF00428774. Diabetologia. 1994. PMID: 8150227

5

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.

Hammes HP, Strödter D, Weiss A, Bretzel RG, Federlin K, Brownlee M. Hammes HP, et al. Among authors: brownlee m. Diabetologia. 1995 Jun;38(6):656-60. doi: 10.1007/BF00401835. Diabetologia. 1995. PMID: 7672485

6

Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

Hammes HP, Ali SS, Uhlmann M, Weiss A, Federlin K, Geisen K, Brownlee M. Hammes HP, et al. Among authors: brownlee m. Diabetologia. 1995 Mar;38(3):269-73. doi: 10.1007/BF00400629. Diabetologia. 1995. PMID: 7758871

7

Pericytes and the pathogenesis of diabetic retinopathy.

Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U. Hammes HP, et al. Among authors: brownlee m. Diabetes. 2002 Oct;51(10):3107-12. doi: 10.2337/diabetes.51.10.3107. Diabetes. 2002. PMID: 12351455

8

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Hammes HP, et al. Among authors: brownlee m. Nat Med. 2003 Mar;9(3):294-9. doi: 10.1038/nm834. Epub 2003 Feb 18. Nat Med. 2003. PMID: 12592403

9

Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.

Hoffmann J, Alt A, Lin J, Lochnit G, Schubert U, Schleicher E, Chavakis T, Brownlee M, Van der Woude FJ, Preissner KT, Hammes HP. Hoffmann J, et al. Among authors: brownlee m. Thromb Haemost. 2006 Apr;95(4):689-95. Thromb Haemost. 2006. PMID: 16601840

10

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.

Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Hammes HP, et al. Among authors: brownlee m. Nat Med. 1996 May;2(5):529-33. doi: 10.1038/nm0596-529. Nat Med. 1996. PMID: 8616710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters